"There's no peer review that's been done on this data," he added. "They rush out a flash study that supposedly found that global warming boosted fire weather conditions in the area by 35% and ...

From left, John Bockstanz, innovation policy manager at Meta, joins Julian Saks, founder of Finetune, Kal Clark, CEO of Zauron Labs, and Mark Heaps, Groq's chief tech evangelist, in a panel ...

In this article, we are going to take a look at where Meta Platforms Inc (NASDAQ:META) stands against other AI stocks on Wall Street’s radar after DeepSeek breakthrough. AI investors are ...

Meta Platforms posted $48.39 billion in revenue, up 21% year-over-year. EPS came in at $8.02 per share and trounced Wall Street’s $6.76 estimate. Net income also rose 49% to $20.84 billion.

Meta Platforms (NASDAQ: META) is coming off one of the best years in its history in 2024. The stock jumped 65% as it delivered strong growth throughout the year on the top and bottom lines.

A Price to Earnings ratio of 31.82 significantly below the industry average by 0.47x suggests undervaluation. This can make the stock appealing for those seeking growth. It could be trading at a ...

Now the company, since renamed Meta, has actually done it. Except it weighs a half a ton, costs $2 million, and won’t ever leave the lab. Still, it’s pretty cool that neuroscience and AI ...

Meta Platforms (META) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance ...

"This is a marathon, not a sprint," he said in a recording reviewed by Business Insider. "But honestly, this year feels a little more like a sprint to me." Meta declined to comment. Meta is ...

It's a change that has prompted a lawyer to drop Meta as a client due to its CEO's "descent into toxic masculinity and Neo-Nazi madness." Stanford law professor Mark Lemley represented Meta in a ...

PARK CITY, Utah, February 07, 2025--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in implantable Tibial NeuroModulation (iTNM) and developer of the Revi ® System, a patient-centric solution for ...

Right off the bat, you'll notice this isn't the Meta Quest 4. Instead, it's a more entry-level alternative to the Meta Quest 3, like the Xbox Series S is to the Series X. At best, it's $200 ...